期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CURRENT PHARMACEUTICAL BIOTECHNOLOGY LetPub Score 5.4
50 ratings
Rate
Reputation 6.4 Influence 4.1 Speed 7.0 | ||||||||||||||||||||
期刊簡稱 | CURR PHARM BIOTECHNO | ||||||||||||||||||||
ISSN | 1389-2010 | ||||||||||||||||||||
E-ISSN | 1873-4316 | ||||||||||||||||||||
h-index | 73 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 4.50%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://benthamscience.com/journal/index.php?journalID=cpb | ||||||||||||||||||||
在線稿件提交 | http://benthamscience.com/journal/authors-guidelines.php?journalID=cpb#top | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Bentham Science Publishers B.V. | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||
創刊年 | 2000 | ||||||||||||||||||||
每年文章數 | 139每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 0.66% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1389-2010%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Ordinary, 3-6 Week(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[CURRENT PHARMACEUTICAL BIOTECHNOLOGY] 的評論 | 撰寫評論 |
作者: zero 00 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-28 10:58:52 評論於 It took more than two months to start the external review, which is supposed to take 2-4 weeks according to the external review website. It has been over 3 weeks now and still no news(0) 讚! | zero 00 |
作者: Andre Eliot 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-02 11:05:07 評論於 How did it go later? Did you pay for the fast pass?(0) 讚! | Andre Eliot |
作者: TonyCJLU 領域: 生物学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-09-21 09:01:02 評論於 Four reviewers provided a lot of comments, and the students made efforts to revise and supplemented with two additional experiments. The overall charges collected are not low, and if the fast publication fee is not paid, the formal publication will be particularly slow.(2) 讚! | TonyCJLU |
作者: 平原海雁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-19 12:38:45 評論於 Review speed: 24.0 experience sharing: two months, no news after submission. Only received one email for paid expedited review, haha(0) 讚! | 平原海雁 |
作者: gliangw 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2021-10-19 08:55:37 評論於 Received: August 13, 2020 Revised: October 23, 2020 Accepted: October 23, 2020 The Impact Factor (IF) announced in 2021 has reached 2.837, showing a significant increase compared to the previous year. Students who have graduation requirements may consider submitting their work.(1) 讚! | gliangw |
作者: 匿名 領域: 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2013-11-23 14:47:00 評論於 Journal Homepage URL: http://www.benthamsciencepublisher.com/cpb/(0) 讚! | 匿名 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-11-28 21:01:59 評論於 Can we make it to top 3 next year? Let's discuss(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us